title: [Effects of incretin on cardiovascular disease and risk factors].
abstract: Diabetes is an important poor prognostic factor for ischemic heart disease and other cardiovascular diseases. Various study results have previously shown that new diabetes therapeutic agents including GLP-1 agonists and DPP-4 inhibitors have been suggested to be able to not only improve the pathology of diabetes, but also improve cardiovascular risk and be useful in prognosis. This report describes the effects of incretin on the cardiovascular system and its expected efficacy in reducing cardiovascular risk.
authors: Department of Cardiovascular and Renal Medicine, Saga University.
authors: Kazuhisa
authors: K
authors: Kodama
authors: Koichi
authors: K
authors: Node